To further study resistance mechanisms to JAK inhibitors in CBFA2T3::GLIS2 AML, we developed CBFA2T3::GLIS2 AML cell lines with acquired resistance to JAK inhibitors. The gene discussed is CBFA2T3; the disease is acute myeloid leukemia.